Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 Nov;54(2):289–297.

Early events in the host-parasite relationship and immune response in clinical leprosy: its possible importance for leprosy control.

G Bjune, O Closs, R S Barnetson
PMCID: PMC1535902  PMID: 6228348

Full text

PDF
289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe M., Izumi S., Saito T., Mathur S. K. Early serodiagnosis of leprosy by indirect immunofluorescence. Lepr India. 1976 Jul;48(3):272–276. [PubMed] [Google Scholar]
  2. Abe M., Minagawa F., Yoshino Y., Ozawa T., Saikawa K., Saito T. Fluorescent leprosy antibody absorption (FLA-ABS) test for detecting subclinical infection with Mycobacterium leprae. Int J Lepr Other Mycobact Dis. 1980 Jun;48(2):109–119. [PubMed] [Google Scholar]
  3. Ashman R. B., Nahmias A. J. Enhancement of human lymphocyte responses to phytomitogens in vitro by incubation at elevated temperatures. Clin Exp Immunol. 1977 Sep;29(3):464–467. [PMC free article] [PubMed] [Google Scholar]
  4. BRAND P. W. Temperature variation and leprosy deformity. Int J Lepr. 1959 Jan-Mar;27(1):1–7. [PubMed] [Google Scholar]
  5. Barnetson R. S., Bjune G., Pearson J. M., Kronvall G. Antigenic heterogeneity in patients with reactions in borderline leprosy. Br Med J. 1975 Nov 22;4(5994):435–437. doi: 10.1136/bmj.4.5994.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bjorvatn B., Barnetson R. S., Kronvall G., Zubler R. H., Lambert P. H. Immune complexes and complement hypercatabolism in patients with leprosy. Clin Exp Immunol. 1976 Dec;26(3):388–396. [PMC free article] [PubMed] [Google Scholar]
  7. Bjune G., Barnetson R. S. Plasma factors in delayed-type hypersensitivity. Augmentation of lymphocyte responses in borderline leprosy reactions. Clin Exp Immunol. 1976 Dec;26(3):397–402. [PMC free article] [PubMed] [Google Scholar]
  8. Bjune G., Barnetson R. S., Ridley D. S., Kronvall G. Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions. Clin Exp Immunol. 1976 Jul;25(1):85–94. [PMC free article] [PubMed] [Google Scholar]
  9. Buckton K. E., Brown W. M., Smith P. G. Lymphocyte survival in men treated with x-rays for ankylosing spondylitis. Nature. 1967 Apr 29;214(5087):470–473. doi: 10.1038/214470a0. [DOI] [PubMed] [Google Scholar]
  10. Closs O. Experimental murine leprosy: induction of immunity and immune paralysis to Mycobacterium lepraemurium in C57BL mice. Infect Immun. 1975 Oct;12(4):706–713. doi: 10.1128/iai.12.4.706-713.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Closs O., Mshana R. N., Harboe M. Antigenic analysis of Mycobacterium leprae. Scand J Immunol. 1979 Mar;9(3):297–302. doi: 10.1111/j.1365-3083.1979.tb02735.x. [DOI] [PubMed] [Google Scholar]
  12. Closs O., Reitan L. J. In vitro lymphocyte stimulation using a purified antigen of Mycobacterium leprae and tuberculin PPD. Lepr Rev. 1981 Dec;52 (Suppl 1):251–262. [PubMed] [Google Scholar]
  13. Closs O., Reitan L. J., Negassi K., Harboe M., Belehu A. In vitro stimulation of lymphocytes in leprosy patients, healthy contacts of leprosy patients, and subjects not exposed to leprosy. Comparison of an antigen fraction prepared from Mycobacterium leprae and tuberculin-purified protein derivative. Scand J Immunol. 1982 Aug;16(2):103–115. doi: 10.1111/j.1365-3083.1982.tb00704.x. [DOI] [PubMed] [Google Scholar]
  14. Coates A. R., Hewitt J., Allen B. W., Ivanyi J., Mitchison D. A. Antigenic diversity of Mycobacterium tuberculosis and Mycobacterium bovis detected by means of monoclonal antibodies. Lancet. 1981 Jul 25;2(8239):167–169. doi: 10.1016/s0140-6736(81)90355-x. [DOI] [PubMed] [Google Scholar]
  15. Draper P., Rees R. J. Electron-transparent zone of mycobacteria may be a defence mechanism. Nature. 1970 Nov 28;228(5274):860–861. doi: 10.1038/228860a0. [DOI] [PubMed] [Google Scholar]
  16. Draper P. The walls of Mycobacterium lepraemurium: chemistry and ultrastructure. J Gen Microbiol. 1971 Dec;69(3):313–324. doi: 10.1099/00221287-69-3-313. [DOI] [PubMed] [Google Scholar]
  17. Etemadi A. H., Convit J. Mycolic acids from "noncultivable" mycobacteria. Infect Immun. 1974 Jul;10(1):236–239. doi: 10.1128/iai.10.1.236-239.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. FENNER F., MARTIN S. P., PIERCE C. H. The enumeration of viable tubercle bacilli in cultures and infected tissues. Ann N Y Acad Sci. 1949 Dec 14;52(5):751-64, illust. doi: 10.1111/j.1749-6632.1949.tb53966.x. [DOI] [PubMed] [Google Scholar]
  19. Gillis T. P., Buchanan T. M. Production and partial characterization of monoclonal antibodies to Mycobacterium leprae. Infect Immun. 1982 Jul;37(1):172–178. doi: 10.1128/iai.37.1.172-178.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Godal T., Lofgren M., Negassi K. Immune response to M. leprae of healthy leprosy contacts. Int J Lepr Other Mycobact Dis. 1972 Jul-Sep;40(3):243–250. [PubMed] [Google Scholar]
  21. Godal T., Negassi K. Subclinical infection in leprosy. Br Med J. 1973 Sep 15;3(5880):557–559. doi: 10.1136/bmj.3.5880.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Harboe M. Radioimmunoassay and other serologic tests and their application in epidemiological work. Lepr Rev. 1981 Dec;52 (Suppl 1):275–288. doi: 10.5935/0305-7518.19810077. [DOI] [PubMed] [Google Scholar]
  23. Hart P. D., Armstrong J. A., Brown C. A., Draper P. Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria. Infect Immun. 1972 May;5(5):803–807. doi: 10.1128/iai.5.5.803-807.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hirschberg H. The role of macrophages in the lymphoproliferative response to Mycobacterium leprae in vitro. Clin Exp Immunol. 1978 Oct;34(1):46–51. [PMC free article] [PubMed] [Google Scholar]
  25. Hunter S. W., Brennan P. J. A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J Bacteriol. 1981 Sep;147(3):728–735. doi: 10.1128/jb.147.3.728-735.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Jackett P. S., Aber V. R., Lowrie D. B. Virulence of Mycobacterium tuberculosis and susceptibility to peroxidative killing systems. J Gen Microbiol. 1978 Aug;107(2):273–278. doi: 10.1099/00221287-107-2-273. [DOI] [PubMed] [Google Scholar]
  27. Karat A. B., Job C. K., Rao P. S. Liver in leprosy: histological and biochemical findings. Br Med J. 1971 Feb 6;1(5744):307–310. doi: 10.1136/bmj.1.5744.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kronvall G., Stanford J. L., Walsh G. P. Studies of mycobacterial antigens, with special reference to Mycobacterium leprae. Infect Immun. 1976 Apr;13(4):1132–1138. doi: 10.1128/iai.13.4.1132-1138.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kronvall G. The potential of immunological tests as tools in the epidemiology of leprosy. Lepr Rev. 1981 Dec;52 (Suppl 1):207–219. doi: 10.5935/0305-7518.19810071. [DOI] [PubMed] [Google Scholar]
  30. LARA C. B., NOLASCO J. O. Self-healing, or abortive, and residual forms of childhood leprosy and their probable significance. Int J Lepr. 1956 Jul-Sep;24(3):245–263. [PubMed] [Google Scholar]
  31. Leake E. S., Myrvik Q. N. Digestive vacuole formation in alveolar macrophages after phagocytosis of Mycobacterium smegmatis in vivo. J Reticuloendothel Soc. 1966 May;3(1):83–100. [PubMed] [Google Scholar]
  32. Lyberg T., Closs O., Prydz H. Effect of purified protein derivative and sonicates of Mycobacterium leprae and Mycobacterium bovis BCG on thromboplastin response in human monocytes in vitro. Infect Immun. 1982 Dec;38(3):855–859. doi: 10.1128/iai.38.3.855-859.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mehra V., Mason L. H., Fields J. P., Bloom B. R. Lepromin-induced suppressor cells in patients with leprosy. J Immunol. 1979 Oct;123(4):1813–1817. [PubMed] [Google Scholar]
  34. Menzel S., Bjune G., Kronvall G. Lymphocyte transformation test in healthy contacts of patients with leprosy. I. Influence of exposure to leprosy within a household. Int J Lepr Other Mycobact Dis. 1979 Jun;47(2):138–152. [PubMed] [Google Scholar]
  35. Mshana R. N., Haregewoin A., Harboe M., Belehu A. Thymus dependent lymphocytes in leprosy. I. T lymphocyte subpopulations defined by monoclonal antibodies. Int J Lepr Other Mycobact Dis. 1982 Sep;50(3):291–296. [PubMed] [Google Scholar]
  36. Nelson D. S., Penrose J. M., Waters M. F., Pearson J. M., Nelson M. Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment. Clin Exp Immunol. 1975 Dec;22(3):385–392. [PMC free article] [PubMed] [Google Scholar]
  37. Paul R. C., Stanford J. L., Carswell J. W. Multiple skin testing in leprosy. J Hyg (Lond) 1975 Aug;75(1):57–68. doi: 10.1017/s0022172400047069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Paul R. C., Stanford J. L., Misljenóvic O., Lefering J. Multiple skin testing of Kenyan schoolchildren with a series of new tuberculins. J Hyg (Lond) 1975 Oct;75(2):303–313. doi: 10.1017/s002217240004732x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  40. Ridley D. S. The pathogenesis of the early skin lesion in leprosy. J Pathol. 1973 Nov;111(3):191–206. doi: 10.1002/path.1711110307. [DOI] [PubMed] [Google Scholar]
  41. Rook G. A. The potentiating, mitogenic and inhibitory effects on lymphocytes in vitro, of macrophages in the lymph nodes of mice 'overloaded' with mycobacterial products. Clin Exp Immunol. 1975 Jul;21(1):163–172. [PMC free article] [PubMed] [Google Scholar]
  42. SALVIN S. B. Occurrence of delayed hypersensitivity during the development of Arthus type hypersensitivity. J Exp Med. 1958 Jan 1;107(1):109–124. doi: 10.1084/jem.107.1.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. SHEPARD C. C. The nasal excretion of Mycobacterium leprae in leprosy. Int J Lepr. 1962 Jan-Mar;30:10–18. [PubMed] [Google Scholar]
  44. Stanford J. L., Rook G. A., Convit J., Godal T., Kronvall G., Rees R. J., Walsh G. P. Preliminary taxonomic studies on the leprosy bacillus. Br J Exp Pathol. 1975 Dec;56(6):579–585. [PMC free article] [PubMed] [Google Scholar]
  45. Stoner G. L., Touw J., Belehu A., Naafs B. In-vitro lymphoproliferative response to Mycobacterium leprae of HLA-D-identical siblings of lepromatous leprosy patients. Lancet. 1978 Sep 9;2(8089):543–547. doi: 10.1016/s0140-6736(78)92881-7. [DOI] [PubMed] [Google Scholar]
  46. Wemambu S. N., Turk J. L., Waters M. F., Rees R. J. Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet. 1969 Nov 1;2(7627):933–935. doi: 10.1016/s0140-6736(69)90592-3. [DOI] [PubMed] [Google Scholar]
  47. Widebäck K., Kronvall G., Bjorvatn B., Closs O., Harboe M. Comparative studies of antigen 21 in Mycobacterium and Nocardia species: possible taxonomic relationships with Mycobacterium leprae. Infect Immun. 1980 Nov;30(2):413–420. doi: 10.1128/iai.30.2.413-420.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Youmans A. S., Youmans G. P. Preparation of highly immunogenic ribosomal fractions of Mycobacterium tuberculosis by use of sodium dodecyl sulfate. J Bacteriol. 1966 Jun;91(6):2139–2145. doi: 10.1128/jb.91.6.2139-2145.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. de Vries R. R., Fat R. F., Nijenhuis L. E., van Rood J. J. HLA-linked genetic control of host response to Mycobacterium leprae. Lancet. 1976 Dec 18;2(7999):1328–1330. doi: 10.1016/s0140-6736(76)91975-9. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES